The breast imaging market has been reinvigorated with an expanding arsenal of diagnostic and screening technologies for breast cancer. The recent FDA clearance of Fuji’s FCRm system, the anticipated arrival of new CR systems for mammography, not to mention GE’s newcomer — MR spectroscopy for breast — are positioned to fill the void left by FFDM and redefine breast imaging.
DMIST Sparks Trend in FFDM



As scientists focus on eradicating cancer, heart and neurological disorders, innovations in medical imaging and IT are bringing us closer to prevention, treatments and cures for these deadly diseases.


Taking a MRI-guided breast biopsy in real time is a recent development and an important advancement in diagnosing breast cancer today. And while ITN recognizes our readers’ interest in timely applications for patients currently suffering from disease, on occasion, we look ahead to gain some perspective on the here and now.



What is Ziehm’s mission in the U.S. market?
Ströbel: In imaging, with our competitors, we are a little bit smaller in size. We are a technology-driven company, so that means we try to be innovative, and we deliver new products and new solutions in a short rate. What we need for that is market perceptiveness. Many people come here to learn about the latest medical advancements. We are able to identify trends and convert them within our innovative engineering company so that we have new products ready to go.


Dr. Katsumi Nakamura of Tobata Kyoritsu Hospital in Japan received first place honors at the 14th annual International Society for Magnetic Resonance in Medicine (ISMRM) meetings for research in non-contrast MRA imaging. Nakamura received the honors for his presentation comparing non-contrast fresh blood imaging (FBI) to 16-slice CT for the diagnosis of peripheral vascular disease using Toshiba’s 1.5 Tesla MRI system.

The Regional Shared Health Information Program (RSHIP), Alberta, Canada, has ordered dozens of Kodak CR and DR systems for installation in 34 hospitals and healthcare centers.
The David Thompson Health and East Central Health Regions ordered 43 Kodak Directview CR systems, one Directview DR 3000 System, six laser imaging systems, six film digitizers and a Kodak Directview Capture Link Systems, designed for cassette identification, scanning and image review functions on any networked Kodak CR systems.

Clinicians at the Virginia Commonwealth University Massey Cancer Center use new image-guided radiosurgery (IGRS) technology to control the spread of metastatic cancer.

The new Totoku ME551i2 display for digital mammography will come by the Matrox MED5mp technology.
The new Totoku ME551i2 is a high-resolution 5 MP medical display designed for digital mammography and other advanced applications, and simultaneously displays 2048 shades of gray to enable grayscale suitable for the DICOM GSDF. The new display will roll out bundled with the Totoku LV52P1 display controller board, which is based on the Matrox MED 5 MP technology.

Since the beginning of 2006, GE Healthcare’s global ultrasound business has generated $671 million in sales -- a 15 percent increase from 2005. This continues a ten-year trend of double digit growth for ultrasound. The company attributes the success to their strategic focus on ultrasound, investment in expanding services and the introduction of compact and volume ultrasound systems.

Toshiba America Medical Systems, Inc. will display Aquilion Large Bore, the industry’s largest bore CT for clinical oncology, at this year’s American Society for Therapeutic Radiology and Oncology (ASTRO) meeting in Philadelphia, held November 5-9, 2006.
Toshiba’s large bore opening is 90 cm, offers a 70 cm acquired field-of-viewand is designed to enable accurate scanning of patients of all sizes in various positions during CT simulation.

Subscribe Now